聚炎中颗粒瘤的活性及其与中性粒细胞中mTOR脂蛋白组的相关性
Marcin Surmiak1, Katarzyna Wawrzycka-Adamczyk2, Joanna Kosałka-Węgiel2
1Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
Frontiers in immunology
|September 18, 2023
概括
在带有多炎 (GPA) 的颗粒瘤症中,受抑制的哺乳动物目标拉巴胺素 (mTOR) 信号传输与中性粒细胞外细胞陷形成 (NETosis) 有关. 这一发现表明,自可能在GPA颗粒瘤的发展中起作用.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 类风湿病学 类风湿病学
背景情况:
- 带有多管炎 (GPA) 的颗粒性血管炎是一种小血管血管炎,其特征是复杂的病理机制和器官损伤.
- 中性细胞外细胞陷形成 (NETosis) 参与了GPA的发病.
研究的目的:
- 为了研究在哺乳动物的目标拉巴胺素 (mTOR) 途径中光蛋白的功能状态,该途径调节了GPA中的NETosis.
- 分析与这些脂蛋白相关的NETosis生物标志物.
主要方法:
- 从42名GPA患者 (21名活跃,21名缓解) 和21名健康对照中分离出了中性粒细胞.
- 测量和比较了脂蛋白水平和血清生物标志物GPA活性.
- 主要成分分析被用来对疾病状态进行分类.
主要成果:
- 活跃的GPA中性粒细胞显示酸化mTOR,PTEN和ULK1的减少,酸化GSK-3α/β的增加.
- 网症的生物标志物,包括dDNA和线粒体DNA,在活跃的GPA中升高.
- 发现了蛋白水平和GPA活性生物标志物之间的相关性,使用PCA.使用高分类性能 (98%).
结论:
- 抑制的mTOR信号与GPA患者的NETosis有关.
- 蛋白质的形状表明NETosis和自的同时激活.
- 对自在GPA颗粒瘤形成中的作用进行进一步研究是有必要的.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.6K
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
6.0K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
